Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.

Autor: de Carvalho Braga G; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Francisco GR; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Bagatini MD; Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil. margaretebagatini@yahoo.com.br.
Jazyk: angličtina
Zdroj: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Oct; Vol. 102 (10), pp. 1187-1198. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1007/s00109-024-02481-1
Abstrakt: Psoriasis is a chronic condition caused by an inflammation mediated mainly by cytokines and T cells. In COVID-19, the same type of imbalance is common, generating the Cytokine Storm and promoting a worsening in the skin conditions of patients with autoimmune disorders, such as Psoriasis. In this context, one of the main mediators of immune responses presented by SARS-CoV-2 infected patients is the Purinergic System. This immunological resource is capable of stimulating the hyperinflammatory state presented by infected individuals, mainly by the activity of the P2X7 receptor, culminating in the Cytokine Storm and consequently in the Psoriasis crisis. Currently, different drugs are used for patients with Psoriasis, such as immunosuppressants and small molecules; however, the safety of these drugs in infected patients has not been analyzed yet. In this context, studies are being developed to evaluate the possible administration of these traditional drugs to COVID-19 patients with Psoriasis crisis. Along with that, researchers must evaluate the potential of administrating P2X7 antagonists to these patients as well, improving both the systemic and the dermatological prognostics of patients, by reducing the Cytokine Storm and its general effects, but also avoiding the provocation of Psoriasis crisis.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: